HomeRGNX • NASDAQ
add
Regenxbio Inc
Previous close
$16.04
Day range
$15.29 - $15.96
Year range
$11.83 - $28.80
Market cap
781.25M USD
Avg Volume
508.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 22.21M | -29.13% |
Operating expense | 18.50M | 192.30% |
Net income | -62.89M | -4.93% |
Net profit margin | -283.12 | -48.07% |
Earnings per share | -1.43 | -3.62% |
EBITDA | -55.87M | -21.07% |
Effective tax rate | 0.24% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 275.26M | -24.51% |
Total assets | 573.97M | -31.12% |
Total liabilities | 262.23M | -17.30% |
Total equity | 311.74M | — |
Shares outstanding | 44.43M | — |
Price to book | 2.27 | — |
Return on assets | -24.92% | — |
Return on capital | -28.54% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -62.89M | -4.93% |
Cash from operations | -40.76M | -3.53% |
Cash from investing | 33.97M | 27.24% |
Cash from financing | -11.96M | -34.10% |
Net change in cash | -18.75M | 13.17% |
Free cash flow | -18.01M | 21.34% |
About
Founded
2008
Headquarters
Website
Employees
344